ROYAL BANK OF CANADA

Bank

Position in ELDN — Eledon Pharmaceuticals, Inc.

CIK 1000275 TORONTO, A6

Position in ELDN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$23,927

+$20,847 QoQ

Shares Held

6,073

+507.3% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#120

of 159 holders

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. ELDN ranks #213 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	6,182,479	$490,208,754
2	VRTX	Vertex Pharmaceuticals Inc / Ma	980,259	$486,924,048
3	ALNY	Alnylam Pharmaceuticals, Inc.	875,859	$263,659,830
4	INCY	Incyte Corp	1,132,050	$128,329,182
5	REGN	Regeneron Pharmaceuticals, Inc.	174,515	$108,817,078
6	MRNA	Moderna, Inc.	944,457	$66,140,319
7	INSM	INSMED Inc	416,487	$44,405,840
8	HALO	Halozyme Therapeutics, Inc.	545,761	$42,716,712

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,927	6,073	+507.3%	Shares	Defined	2026-08-14
2026-03-31	$3,080	1,000	-37.2%	Shares	Defined	2026-05-15
2025-12-31	$2,403	1,592	-95.8%	Shares	Defined	2026-02-17
2025-09-30	$98,043	37,855	-5.8%	Shares	Defined	2025-11-14
2025-06-30	$108,921	40,193	+100382.5%	Shares	Defined	2025-11-21
2024-06-30	$105	40	0.0%	Shares	Defined	2024-11-06
2024-03-31	$82	40	-63.0%	Shares	Defined	2024-11-05
2023-12-31	$194	108	-99.9%	Shares	Defined	2024-02-14
2023-09-30	$216,742	158,207	-42.1%	Shares	Defined	2023-11-14
2023-06-30	$374,482	273,345	+719228.9%	Shares	Defined	2023-08-14
2022-09-30	$104	38	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.